Plerixafor Accord Unione Europea - lituano - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

PhotoBarr Unione Europea - lituano - EMA (European Medicines Agency)

photobarr

pinnacle biologics b.v.  - porfimer natrio - barrett stemplė - antinavikiniai vaistai - photodynamic terapija (pdt) su photobarr yra nurodyta: abliacijos aukštos kokybės dysplasia (hgd) pacientams su barrett ' s stemplę (bo).

Xorafia Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

xorafia

lv system service sia - sorafenibas - plėvele dengtos tabletės - 200 mg - sorafenib

Desloratadine Teva Unione Europea - lituano - EMA (European Medicines Agency)

desloratadine teva

teva b.v - desloratadinas - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - antihistamininiai vaistai sisteminio naudojimo, - desloratadine teva yra nurodytas atleidimo iš simptomų, susijusių su:alerginiu rinitu;dilgėlinė.

Desloratadine Sopharma Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

desloratadine sopharma

sopharma ad - desloratadinas - geriamasis tirpalas - 0,5 mg/ml - desloratadine

Desloratadine ratiopharm Unione Europea - lituano - EMA (European Medicines Agency)

desloratadine ratiopharm

ratiopharm gmbh - desloratadinas - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamininiai vaistai sisteminio naudojimo, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

Orlistat Polpharma Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

orlistat polpharma

pharmaceutical works polpharma s.a. - orlistatas - kietosios kapsulės - 60 mg; 120 mg - orlistat

Desloratadine Zentiva Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

desloratadine zentiva

zentiva k.s. - desloratadinas - geriamasis tirpalas - 0,5 mg/ml - desloratadine

Desloratadine Sopharma Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

desloratadine sopharma

sopharma ad - desloratadinas - plėvele dengtos tabletės - 5 mg - desloratadine

Sorafenib Accord Unione Europea - lituano - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antinavikiniai vaistai - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.